FI962022A0 - 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina - Google Patents

5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina

Info

Publication number
FI962022A0
FI962022A0 FI962022A FI962022A FI962022A0 FI 962022 A0 FI962022 A0 FI 962022A0 FI 962022 A FI962022 A FI 962022A FI 962022 A FI962022 A FI 962022A FI 962022 A0 FI962022 A0 FI 962022A0
Authority
FI
Finland
Prior art keywords
antivirals
dihydropyrone derivatives
protease inhibitors
dihydropyrone
derivatives
Prior art date
Application number
FI962022A
Other languages
English (en)
Swedish (sv)
Other versions
FI962022A (fi
Inventor
Edmund L Ellsworth
Elizabeth Lunney
Bradley Dean Tait
Original Assignee
Parke Davis & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/319,820 external-priority patent/US5840751A/en
Application filed by Parke Davis & Co filed Critical Parke Davis & Co
Publication of FI962022A0 publication Critical patent/FI962022A0/fi
Publication of FI962022A publication Critical patent/FI962022A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/96Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
FI962022A 1993-11-19 1996-05-13 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina FI962022A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15544393A 1993-11-19 1993-11-19
US08/319,820 US5840751A (en) 1993-11-19 1994-10-12 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
PCT/US1994/012269 WO1995014012A1 (en) 1993-11-19 1994-10-26 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents

Publications (2)

Publication Number Publication Date
FI962022A0 true FI962022A0 (fi) 1996-05-13
FI962022A FI962022A (fi) 1996-07-12

Family

ID=26852338

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962022A FI962022A (fi) 1993-11-19 1996-05-13 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina

Country Status (18)

Country Link
EP (1) EP0729464A1 (fi)
JP (1) JP3684426B2 (fi)
AT (1) ATE263761T1 (fi)
AU (1) AU689158B2 (fi)
CA (1) CA2176043A1 (fi)
DE (1) DE69433705T2 (fi)
DK (1) DK1142887T3 (fi)
ES (1) ES2219457T3 (fi)
FI (1) FI962022A (fi)
HR (1) HRP940935B1 (fi)
HU (1) HUT77668A (fi)
IL (1) IL111674A0 (fi)
NO (1) NO316172B1 (fi)
NZ (1) NZ275961A (fi)
PT (1) PT1142887E (fi)
RU (1) RU2140917C1 (fi)
SI (1) SI1142887T1 (fi)
WO (1) WO1995014012A1 (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69632422T2 (de) * 1995-08-11 2005-05-19 Zenon Environmental Inc., Oakville Verfahren zum Einbetten von Hohlfaser-Membranen
US5834506A (en) * 1996-11-01 1998-11-10 Warner-Lambert Company Dihydropyrones with improved antiviral activity
KR100569771B1 (ko) * 1997-09-11 2006-04-11 파마시아 앤드 업존 캄파니 엘엘씨 프로테아제 억제제로서 유용한 4-히드록시-2-옥소-피란유도체의 제조 방법
AU773567B2 (en) * 1998-09-11 2004-05-27 Warner-Lambert Company HIV protease inhibitors
US6288235B1 (en) 1999-04-14 2001-09-11 Ortho-Mcneil Pharmaceutical, Inc. Methods for the synthesis of highly substituted 2,4-dioxopiperidine libraries
DE10030094A1 (de) * 2000-06-19 2001-12-20 Bayer Ag Phenylsubstituierte 5,6-Dihydro-pyron-Derivate
US6710058B2 (en) 2000-11-06 2004-03-23 Bristol-Myers Squibb Pharma Company Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
DE10108471C1 (de) 2001-02-22 2002-11-21 Boehringer Ingelheim Pharma Kontinuierliches Verfahren zur Herstellung von 5,6-Dihydro-4-hydroxy-2-pyronen
US6500963B2 (en) 2001-02-22 2002-12-31 Boehringer Ingelheim Pharma Kg Process for preparing optically active dihydropyrones
US7141681B2 (en) 2001-02-22 2006-11-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Continuous process for preparing dihydropyrones
DE10108470A1 (de) * 2001-02-22 2002-09-05 Boehringer Ingelheim Pharma Verfahren zur Herstellung optisch aktiver Dihydropyrone
TW200307667A (en) 2002-05-06 2003-12-16 Bristol Myers Squibb Co Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
DOP2003000641A (es) 2002-05-10 2003-11-15 Pfizer Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan
US7148226B2 (en) 2003-02-21 2006-12-12 Agouron Pharmaceuticals, Inc. Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
ES2361845T3 (es) 2004-08-18 2011-06-22 Pfizer, Inc. Inhibidores de arn polimerasa dependiente del arn del virus de la hepatitis c y composiciones y tratamientos que utilizan los mismos.
DE102005059469A1 (de) 2005-12-13 2007-06-14 Bayer Cropscience Ag Insektizide Zusammensetzungen mit verbesserter Wirkung
DE102006007882A1 (de) 2006-02-21 2007-08-30 Bayer Cropscience Ag Cycloalkyl-phenylsubstituierte cyclische Ketoenole
NZ573706A (en) * 2006-06-16 2011-09-30 Pharma Mar Sa Antitumoral dihydropyran-2-one compounds
CN103641709B (zh) 2009-03-11 2017-08-25 拜耳知识产权有限责任公司 被卤代烷基亚甲基氧基苯基取代的酮烯醇
DE102010008644A1 (de) 2010-02-15 2011-08-18 Bayer Schering Pharma Aktiengesellschaft, 13353 Zyklische Ketoenole zur Therapie
RU2461555C1 (ru) * 2011-07-07 2012-09-20 Государственное образовательное учреждение высшего профессионального образования "Пермский государственный университет" Способ получения 5-арил-3-фенил-2-оксаспиро[5,6]додец-3-ен-1-онов, проявляющих анальгетическую активность
DK2806741T3 (da) 2012-01-26 2020-05-18 Bayer Ip Gmbh Phenylsubstituerede ketoenoler til bekæmpelse af fiskeparasitter
JP6205427B2 (ja) 2012-11-28 2017-09-27 住友化学株式会社 ジヒドロピロン化合物及びそれを含有する除草剤
SE539512C2 (sv) * 2015-12-02 2017-10-03 Ultupharma Ab Compounds and methods of treating bacterial infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3818046A (en) * 1972-12-18 1974-06-18 Dow Chemical Co Sulfur-containing hydroxy pyrones and alkali metal salts thereof
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses

Also Published As

Publication number Publication date
AU689158B2 (en) 1998-03-26
ATE263761T1 (de) 2004-04-15
PT1142887E (pt) 2004-08-31
DE69433705T2 (de) 2005-03-10
DK1142887T3 (da) 2004-06-21
SI1142887T1 (en) 2004-08-31
DE69433705D1 (de) 2004-05-13
HU9601348D0 (en) 1996-07-29
NZ275961A (en) 2001-11-30
EP0729464A1 (en) 1996-09-04
JPH09505294A (ja) 1997-05-27
RU2140917C1 (ru) 1999-11-10
CA2176043A1 (en) 1995-05-26
FI962022A (fi) 1996-07-12
JP3684426B2 (ja) 2005-08-17
NO962017D0 (no) 1996-05-15
AU8125694A (en) 1995-06-06
IL111674A0 (en) 1995-01-24
HRP940935A2 (en) 1997-04-30
WO1995014012A1 (en) 1995-05-26
ES2219457T3 (es) 2004-12-01
HUT77668A (hu) 1998-07-28
HRP940935B1 (en) 2004-08-31
NO316172B1 (no) 2003-12-22
NO962017L (no) 1996-07-08

Similar Documents

Publication Publication Date Title
FI962022A0 (fi) 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
MY138860A (en) Hiv protease inhibitors.
DK0729463T3 (da) 5,6-Dihydropyronderivater som proteaseinhibitorer og antivirale midler
MD960171A (ro) Derivaţi ai pironei folosiţi ca inhibitori ai proteazei şi agenţi antivirali
FI962020A0 (fi) Pyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
NO962015L (no) Pyron-derivater som protease-inhibitorer og antivirus-midler